IDEAYA Biosciences, Inc. (IDYA) has a consensus analyst rating of Buy, based on 24 analysts covering the stock. Of those, 22 recommend buying, 2 recommend holding, and 0 recommend selling.
The analyst consensus price target for IDYA is $46.75, representing a +44.5% upside from the current price of $32.35. Price targets range from a low of $30.00 to a high of $60.00.
